Clincosm LogoSign in Get a demo

Peripheral T-cell Lymphoma

Showing 1 - 25 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral T-cell Lymphoma Trial (Linperlisib in combination with CHOP)

Not yet recruiting
  • Peripheral T-cell Lymphoma
  • Linperlisib in combination with CHOP
  • (no location specified)
Jul 10, 2023

Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma Trial run by the NCI (Romidepsin,

Recruiting
  • Cutaneous T-Cell Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Peripheral T-cell Lymphoma Trial in Worldwide (Romidepsin + CHOP, CHOP)

Completed
  • Peripheral T-cell Lymphoma
  • Antwerpen, Belgium
  • +130 more
Jan 9, 2023

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Peripheral T-cell Lymphoma Trial in Worldwide (brentuximab vedotin, cyclophosphamide, doxorubicin)

Recruiting
  • Peripheral T-cell Lymphoma
  • brentuximab vedotin
  • +3 more
  • Birmingham, Alabama
  • +45 more
Jan 4, 2023

B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Peripheral T-Cell Lymphoma Trial in Columbus (Letermovir)

Recruiting
  • B-Cell Prolymphocytic Leukemia
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 18, 2022

Peripheral T-Cell Lymphoma, Lenalidomide, CHOP Trial in Hangzhou (Lenalidomide, Cyclophosphamide, Doxorubicin)

Recruiting
  • Peripheral T-Cell Lymphoma
  • +2 more
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 3, 2022

T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

Not yet recruiting
  • T-cell Lymphoma
  • +10 more
  • Chicago, Illinois
    Rush University Medical Center
Oct 24, 2022

Peripheral T-cell Lymphoma Trial in Beijing (AK104)

Terminated
  • Peripheral T-cell Lymphoma
  • AK104
  • Beijing, Beiing, China
    Beijing Cancer Hospital
Oct 17, 2022

Peripheral T-cell Lymphoma Trial in Tianjin (Lposomal mitoxantrone HCl,Cyclophosphamide,Vincristine,Etoposide and

Not yet recruiting
  • Peripheral T-cell Lymphoma
  • Lposomal mitoxantrone hydrochloride,Cyclophosphamide,Vincristine,Etoposide and Prednisone(CMOEP)
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
Jul 13, 2022

Treatment, Peripheral T-cell Lymphoma Trial in Beijing (liposomal mitoxantrone HCl, gemcitabine, dexamethasone, and cisplatin)

Recruiting
  • Treatment
  • Peripheral T-cell Lymphoma
  • liposomal mitoxantrone hydrochloride, gemcitabine, dexamethasone, and cisplatin
  • Beijing, China
  • +4 more
Jun 28, 2022

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Peripheral T-cell Lymphoma Trial in Worldwide (Duvelisib)

Active, not recruiting
  • Peripheral T-cell Lymphoma
  • Duarte, California
  • +27 more
May 3, 2022

Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,

Recruiting
  • Cutaneous T-cell Lymphoma
  • +4 more
  • Columbus, Ohio
    The Ohio State University Cancer Center
Apr 18, 2022

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Active, not recruiting
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +16 more
  • 6,8-bis(benzylthio)octanoic acid
  • bendamustine hydrochloride
  • Winston-Salem, North Carolina
  • +1 more
Apr 8, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • +12 more
    • Bedford, Bedfordshire, United Kingdom
    • +8 more
    Feb 22, 2022

    Peripheral T-Cell Lymphoma Trial in Zhengzhou (Parsaclisib, Chidamide)

    Not yet recruiting
    • Peripheral T-Cell Lymphoma
    • Zhengzhou, Henan, China
      Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
    Dec 26, 2021

    Peripheral T-cell Lymphoma Trial in Shanghai (PD-1 antibody+ HDAC inhibitor)

    Recruiting
    • Peripheral T-cell Lymphoma
    • PD-1 antibody+ HDAC inhibitor
    • Shanghai, Shanghai, China
      Dongmei Ji
    Dec 3, 2021

    Peripheral T-cell Lymphoma Trial in Worldwide (Pralatrexate Injection)

    Terminated
    Has Results
    • Peripheral T-cell Lymphoma
    • Pralatrexate Injection
    • Novi, Michigan
    • +54 more
    Nov 18, 2021

    Peripheral T-cell Lymphoma Trial in Worldwide (Belinostat)

    Completed
    Has Results
    • Peripheral T-cell Lymphoma
    • Duarte, California
    • +116 more
    Oct 14, 2021

    Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

    Terminated
    Has Results
    • Adult Grade III Lymphomatoid Granulomatosis
    • +116 more
    • brentuximab vedotin
    • +2 more
    • Chicago, Illinois
    • +2 more
    Aug 30, 2021

    Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma Trial in Canada, United States (ABT-263)

    Completed
    • Chronic Lymphoid Leukemia
    • +5 more
    • Los Angeles, California
    • +11 more
    Jul 28, 2021

    Peripheral T-Cell Lymphoma Trial in Worldwide (SP-02L (darinaparsin for injection))

    Completed
    • Peripheral T-Cell Lymphoma
    • SP-02L (darinaparsin for injection)
    • Hong Kong, Hong Kong
    • +23 more
    Jul 22, 2021

    Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma Trial in Japan (E7777)

    Completed
    Has Results
    • Peripheral T-cell Lymphoma
    • Cutaneous T-cell Lymphoma
    • Nagoya, Aichi, Japan
    • +19 more
    Jun 24, 2021